Efficacy of flow restrictors in limiting access of liquid medications by young children

Maribeth C Lovegrove1, Stephanie Hon, Robert J Geller

  • 1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.

Insights

Flow restrictors (FRs) significantly reduce unsupervised liquid medicine ingestion by young children. Adding FRs to bottles offers enhanced protection, even if child-resistant caps are not fully secured.

Area of Science:

  • Pediatric safety
  • Consumer product safety

Background:

  • Unsupervised ingestion of liquid medications by young children poses a significant safety risk.
  • Child-resistant packaging is a primary safety measure, but its effectiveness can be compromised if not fully secured.

Purpose of the Study:

  • To evaluate the efficacy of flow restrictors (FRs) in preventing unsupervised medication access by young children.
  • To determine if FRs provide additional safety benefits beyond standard child-resistant closures.

Main Methods:

  • A randomized trial involved 110 children aged 3-4 years attempting to access liquid from bottles.
  • Test bottles included uncapped versions with FRs and control bottles without FRs (uncapped or incompletely closed).
  • Children's ability to remove liquid within a 10-minute period was measured.

Main Results:

  • Bottles with FRs were significantly less likely to be emptied compared to control bottles (6% vs. 82-96% emptied).
  • Children removed substantially less liquid from bottles with FRs (P < .001).
  • A higher percentage of children removed less than 25 mL from bottles with FRs compared to controls.

Conclusions:

  • Flow restrictors (FRs) effectively limit young children's access to liquid medications.
  • FRs can serve as a valuable complementary safety feature to existing child-resistant packaging for liquid medicine bottles.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...